Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone.

Lorenz N, Dänicke S, Edler L, Gottschalk C, Lassek E, Marko D, Rychlik M, Mally A.

Mycotoxin Res. 2019 Feb;35(1):27-46. doi: 10.1007/s12550-018-0328-z. Epub 2018 Sep 13.

2.

Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation.

Hüser S, Guth S, Joost HG, Soukup ST, Köhrle J, Kreienbrock L, Diel P, Lachenmeier DW, Eisenbrand G, Vollmer G, Nöthlings U, Marko D, Mally A, Grune T, Lehmann L, Steinberg P, Kulling SE.

Arch Toxicol. 2018 Sep;92(9):2703-2748. doi: 10.1007/s00204-018-2279-8. Epub 2018 Aug 21. Review.

3.

Exposure assessment of process-related contaminants in food by biomarker monitoring.

Rietjens IMCM, Dussort P, Günther H, Hanlon P, Honda H, Mally A, O'Hagan S, Scholz G, Seidel A, Swenberg J, Teeguarden J, Eisenbrand G.

Arch Toxicol. 2018 Jan;92(1):15-40. doi: 10.1007/s00204-017-2143-2. Epub 2018 Jan 4. Review.

4.

Linking site-specific loss of histone acetylation to repression of gene expression by the mycotoxin ochratoxin A.

Limbeck E, Vanselow JT, Hofmann J, Schlosser A, Mally A.

Arch Toxicol. 2018 Feb;92(2):995-1014. doi: 10.1007/s00204-017-2107-6. Epub 2017 Nov 2.

PMID:
29098329
5.

Quantitative targeted bile acid profiling as new markers for DILI in a model of methapyrilene-induced liver injury in rats.

Slopianka M, Herrmann A, Pavkovic M, Ellinger-Ziegelbauer H, Ernst R, Mally A, Keck M, Riefke B.

Toxicology. 2017 Jul 1;386:1-10. doi: 10.1016/j.tox.2017.05.009. Epub 2017 May 19.

PMID:
28529062
6.

Functional and cellular consequences of covalent target protein modification by furan in rat liver.

Ramm S, Limbeck E, Mally A.

Toxicology. 2016 Jun 15;361-362:49-61. doi: 10.1016/j.tox.2016.06.018. Epub 2016 Jul 9.

PMID:
27402187
7.

Biomonitoring of the mycotoxin Zearalenone: current state-of-the art and application to human exposure assessment.

Mally A, Solfrizzo M, Degen GH.

Arch Toxicol. 2016 Jun;90(6):1281-92. doi: 10.1007/s00204-016-1704-0. Epub 2016 Mar 31. Review.

PMID:
27034246
8.

Assessment of global and gene-specific DNA methylation in rat liver and kidney in response to non-genotoxic carcinogen exposure.

Ozden S, Turgut Kara N, Sezerman OU, Durasi İM, Chen T, Demirel G, Alpertunga B, Chipman JK, Mally A.

Toxicol Appl Pharmacol. 2015 Dec 1;289(2):203-12. doi: 10.1016/j.taap.2015.09.023. Epub 2015 Sep 30.

PMID:
26431795
9.

Application of a discovery to targeted LC-MS proteomics approach to identify deregulated proteins associated with idiosyncratic liver toxicity in a rat model of LPS/diclofenac co-administration.

Ramm S, Morissey B, Hernandez B, Rooney C, Pennington SR, Mally A.

Toxicology. 2015 May 4;331:100-11. doi: 10.1016/j.tox.2015.03.004. Epub 2015 Mar 13.

PMID:
25772430
10.

Application of RNA interference to improve mechanistic understanding of omics responses to a hepatotoxic drug in primary rat hepatocytes.

Adler M, Leich E, Ellinger-Ziegelbauer H, Hewitt P, Dekant W, Rosenwald A, Mally A.

Toxicology. 2014 Dec 4;326:86-95. doi: 10.1016/j.tox.2014.10.007. Epub 2014 Oct 22.

PMID:
25456269
11.

Proposal of a comprehensive definition of modified and other forms of mycotoxins including "masked" mycotoxins.

Rychlik M, Humpf HU, Marko D, Dänicke S, Mally A, Berthiller F, Klaffke H, Lorenz N.

Mycotoxin Res. 2014 Nov;30(4):197-205. doi: 10.1007/s12550-014-0203-5. Epub 2014 Jun 26.

12.

Role of drug-independent stress factors in liver injury associated with diclofenac intake.

Ramm S, Mally A.

Toxicology. 2013 Oct 4;312:83-96. doi: 10.1016/j.tox.2013.08.002. Epub 2013 Aug 9. Erratum in: Toxicology. 2014 Feb 28;316:71-4.

PMID:
23939143
13.

An exploratory evaluation of the utility of transcriptional and urinary kidney injury biomarkers for the prediction of aristolochic acid-induced renal injury in male rats.

Fuchs TC, Mally A, Wool A, Beiman M, Hewitt P.

Vet Pathol. 2014 May;51(3):680-94. doi: 10.1177/0300985813498779. Epub 2013 Aug 2.

PMID:
23912714
14.

Furan carcinogenicity: DNA binding and genotoxicity of furan in rats in vivo.

Neuwirth C, Mosesso P, Pepe G, Fiore M, Malfatti M, Turteltaub K, Dekant W, Mally A.

Mol Nutr Food Res. 2012 Sep;56(9):1363-74. doi: 10.1002/mnfr.201200226. Epub 2012 Aug 3.

15.

Fumonisin B1 and the kidney: modes of action for renal tumor formation by fumonisin B1 in rodents.

Müller S, Dekant W, Mally A.

Food Chem Toxicol. 2012 Oct;50(10):3833-46. doi: 10.1016/j.fct.2012.06.053. Epub 2012 Jul 5. Review.

PMID:
22771819
16.

Furan in heat-treated foods: formation, exposure, toxicity, and aspects of risk assessment.

Moro S, Chipman JK, Wegener JW, Hamberger C, Dekant W, Mally A.

Mol Nutr Food Res. 2012 Aug;56(8):1197-211. doi: 10.1002/mnfr.201200093. Epub 2012 May 29. Review.

PMID:
22641279
17.

Ochratoxin a and mitotic disruption: mode of action analysis of renal tumor formation by ochratoxin A.

Mally A.

Toxicol Sci. 2012 Jun;127(2):315-30. doi: 10.1093/toxsci/kfs105. Epub 2012 Mar 8. Review.

PMID:
22403158
18.

Identification and pathway mapping of furan target proteins reveal mitochondrial energy production and redox regulation as critical targets of furan toxicity.

Moro S, Chipman JK, Antczak P, Turan N, Dekant W, Falciani F, Mally A.

Toxicol Sci. 2012 Apr;126(2):336-52. doi: 10.1093/toxsci/kfs005. Epub 2012 Jan 12.

PMID:
22240984
19.

Gene expression and epigenetic changes by furan in rat liver.

Chen T, Williams TD, Mally A, Hamberger C, Mirbahai L, Hickling K, Chipman JK.

Toxicology. 2012 Feb 26;292(2-3):63-70. doi: 10.1016/j.tox.2011.10.020. Epub 2011 Nov 3.

PMID:
22079235
20.

Integrated transcriptomic and proteomic evaluation of gentamicin nephrotoxicity in rats.

Com E, Boitier E, Marchandeau JP, Brandenburg A, Schroeder S, Hoffmann D, Mally A, Gautier JC.

Toxicol Appl Pharmacol. 2012 Jan 1;258(1):124-33. doi: 10.1016/j.taap.2011.10.015. Epub 2011 Oct 29.

PMID:
22061828

Supplemental Content

Loading ...
Support Center